Pharmacist Sanctioned Over 85,000 Online Prescriptions Without Adequate Safeguards
Date of Decision: November 13, 2025
Registrant's Role: Pharmacist
Allegations:
- Oversight and responsibility for over 85,000 prescriptions including large volumes of high-risk medicines (z-drugs, opioids, modafinil, etc.) without ensuring proper clinical assessment.
- Operated a transactional prescribing model based on patient questionnaires rather than clinical judgement or face-to-face evaluations.
- Repeated failure to ensure compliance with GMC and RPS prescribing guidance, including checks on patient health, GP consultations, and safety-netting.
- Numerous examples of high-risk medicines dispensed multiple times to the same patients without adequate safeguards.
- Specific cases involving unsafe dispensing of medicines like amitriptyline, modafinil, zopiclone, dihydrocodeine, propranolol, and Kapake, where proper clinical processes were ignored.
Outcome: Suspension order of four months
GPhC Standards Breached:
- Standard 1 – Provide person-centred care
- Standard 2 – Work in partnership with others
- Standard 4 – Demonstrate leadership
- Standard 5 – Speak up when there are concerns or when things go wrong
- Standard 6 – Behave professionally
- Standard 7 – Demonstrate leadership (specifically in Superintendent/Responsible Pharmacist roles)
Case Summary
Allegations
This case revolves around the registrant’s conduct while working as both Responsible Pharmacist (RP) and Superintendent Pharmacist (SI) at an online pharmacy, UK Meds Direct Ltd, between 2017 and 2018. During this time, the registrant oversaw a staggering volume of prescribing activity: approximately 85,101 prescriptions, of which over 70,000 were for high-risk medications. These included opioids (33,480), z-drugs (21,336), modafinil (8,723), and various others such as anticonvulsants, amitriptyline, and weight-loss medications.
Crucially, the prescribing model employed was described as “transactional” – based on patient-completed online questionnaires without sufficient clinical oversight. The allegations detailed a systemic failure to ensure prescribers followed GMC and RPS guidance, with deficiencies including:
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
View the Full Determination Document
The original determination transcript is available to registered users.
- Download the official GPhC determination
- Full hearing transcript
- Detailed findings of fact
- Sanction reasoning
- Details of the pharmacy professionals involved